[go: up one dir, main page]

FR1545224A - Procédé de préparation de l'acide sébacique - Google Patents

Procédé de préparation de l'acide sébacique

Info

Publication number
FR1545224A
FR1545224A FR129355A FR129355A FR1545224A FR 1545224 A FR1545224 A FR 1545224A FR 129355 A FR129355 A FR 129355A FR 129355 A FR129355 A FR 129355A FR 1545224 A FR1545224 A FR 1545224A
Authority
FR
France
Prior art keywords
sebacic acid
preparing sebacic
preparing
acid
sebacic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR129355A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5260266A external-priority patent/GB1196594A/en
Application filed by JR Geigy AG filed Critical JR Geigy AG
Priority to FR129355A priority Critical patent/FR1545224A/fr
Application granted granted Critical
Publication of FR1545224A publication Critical patent/FR1545224A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/20—Sebacic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR129355A 1966-12-21 1967-11-23 Procédé de préparation de l'acide sébacique Expired FR1545224A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR129355A FR1545224A (fr) 1966-12-21 1967-11-23 Procédé de préparation de l'acide sébacique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5260266A GB1196594A (en) 1966-12-21 1966-12-21 Improvements in and relating to the production of Sebacic Acid
FR129355A FR1545224A (fr) 1966-12-21 1967-11-23 Procédé de préparation de l'acide sébacique

Publications (1)

Publication Number Publication Date
FR1545224A true FR1545224A (fr) 1968-11-08

Family

ID=26181060

Family Applications (1)

Application Number Title Priority Date Filing Date
FR129355A Expired FR1545224A (fr) 1966-12-21 1967-11-23 Procédé de préparation de l'acide sébacique

Country Status (1)

Country Link
FR (1) FR1545224A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067489A2 (fr) * 2003-01-23 2004-08-12 Esperion Therapeutics, Inc. Composes hydroxyles et compositions de regulation du cholesterol et utilisations associees
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11116739B2 (en) 2015-03-16 2021-09-14 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
US11407705B2 (en) 2019-06-21 2022-08-09 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9000041B2 (en) 2003-01-23 2015-04-07 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10118881B2 (en) 2003-01-23 2018-11-06 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7119221B2 (en) 2003-01-23 2006-10-10 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7335689B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US7335799B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7405226B2 (en) 2003-01-23 2008-07-29 Pfizer Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US7576130B2 (en) 2003-01-23 2009-08-18 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US7812199B2 (en) 2003-01-23 2010-10-12 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US7838554B2 (en) 2003-01-23 2010-11-23 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US8067466B2 (en) 2003-01-23 2011-11-29 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
US8153690B2 (en) 2003-01-23 2012-04-10 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
US8309604B2 (en) 2003-01-23 2012-11-13 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US8497301B2 (en) 2003-01-23 2013-07-30 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US8623915B2 (en) 2003-01-23 2014-01-07 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
WO2004067489A3 (fr) * 2003-01-23 2004-11-25 Esperion Therapeutics Inc Composes hydroxyles et compositions de regulation du cholesterol et utilisations associees
US9452964B2 (en) 2003-01-23 2016-09-27 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
WO2004067489A2 (fr) * 2003-01-23 2004-08-12 Esperion Therapeutics, Inc. Composes hydroxyles et compositions de regulation du cholesterol et utilisations associees
US9624152B2 (en) 2003-01-23 2017-04-18 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10047028B2 (en) 2003-01-23 2018-08-14 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US9006290B2 (en) 2003-01-23 2015-04-14 Esperion Therapeutics, Inc. Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
US10941095B2 (en) 2003-01-23 2021-03-09 Esperion Therapeutics, Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11744816B2 (en) 2015-03-13 2023-09-05 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
US11116739B2 (en) 2015-03-16 2021-09-14 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
US11407705B2 (en) 2019-06-21 2022-08-09 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11613511B2 (en) 2019-06-21 2023-03-28 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11760714B2 (en) 2019-06-21 2023-09-19 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11926584B2 (en) 2019-06-21 2024-03-12 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same
US11987548B2 (en) 2019-06-21 2024-05-21 Esperion Therapeutics, Inc. Methods of making bempedoic acid and compositions of the same

Similar Documents

Publication Publication Date Title
FR1505146A (fr) Procédé de préparation d'acide nitrilo-tris-(méthylènephosphonique)
CH482757A (fr) Procédé de préparation d'acide polyamique
FR1545224A (fr) Procédé de préparation de l'acide sébacique
CH468934A (fr) Procédé de préparation d'acide nitrique concentré
FR1493032A (fr) Procédé de préparation d'acide acétique
FR1487936A (fr) Procédé de préparation de l'acide téréphtalique
FR1515766A (fr) Procédé de préparation de l'acide hydroxytéréphtalique
CH468346A (fr) Procédé de préparation de l'acide 1-amino-3-carboxy-2-propanesulfonique
FR1545225A (fr) Procédé de préparation de l'acide sébacique
FR1525523A (fr) Procédé de préparation de l'acide acétique
FR1449610A (fr) Procédé de préparation de l'acide désacétyl-7-amino-céphalosporanique
FR1462796A (fr) Procédé de préparation de l'acide 4'-nitrodiphényl-4-carboxylique
FR1504089A (fr) Procédé de préparation de l'acide 5-aminovalérique
FR1480084A (fr) Procédé de préparation d'esters de l'acide acétyl-acétique
FR1512534A (fr) Procédé de préparation d'acide adipique
FR1486033A (fr) Procédé de préparation d'acide chloropivalique
FR1537440A (fr) Procédé de préparation de l'acide monochloropivalique
FR1523584A (fr) Procédé de préparation de l'acide isomalique
FR1538202A (fr) Procédé de préparation de l'acide 1-amino-3-carboxy-propane-2-sulfonique
FR1462259A (fr) Procédé de préparation de l'acide delta3-pyrroline-2-carboxylique
CH434236A (fr) Procédé de préparation de l'acide 11-iodo-10-undécynoïque
FR1375060A (fr) Procédé de préparation de l'acide alpha-amino-bêta-hydroxybutyrique
FR1475421A (fr) Procédé de préparation de l'acide trans-4-aminométhylcyclohexane-1-carboxylique pur
CH445479A (fr) Procédé de préparation d'acide trans-4-aminométhyl-cyclohexane-1-carboxylique
FR1433279A (fr) Procédé de préparation de l'acide 5'-guanylique